Following Office of U.S. Trade Representative's (USTR) release of Special 301 Report, BIO shared concern over weak IP enforcement efforts of foreign nations. Report details failings of India, China, Brazil, and Canada, among others, to provide adequate IP protection for biotechnology companies, or their adding of bureaucratic hurdles to patentability. Organization encouraged USTR, in recent Special 301 Submission, to perform out-of-cycle reviews of these countries' patent systems.
This story is related to the following:Trade Associations